Humoral immune response to SARS-CoV-2 third vaccination in patients with multiple sclerosis and healthy controls: A prospective multicenter study

BACKGROUND: Third vaccination against SARS-CoV-2 is recommended for patients with multiple sclerosis (pwMS), usually six months after the last vaccination. METHODS: In this prospective multicenter study on 292 pwMS and 46 healthy controls (HC), who had all received two vaccinations prior to study en...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajnc, Nik, Hegen, Harald, Traxler, Gerhard, Leutmezer, Fritz, Di Pauli, Franziska, Kornek, Barbara, Rommer, Paulus, Zulehner, Gudrun, Riedl, Katharina, Dürauer, Sophie, Bauer, Angelika, Kratzwald, Sarah, Klotz, Sigrid, Winklehner, Michael, Deisenhammer, Florian, Guger, Michael, Höftberger, Romana, Berger, Thomas, Bsteh, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250418/
https://www.ncbi.nlm.nih.gov/pubmed/35797803
http://dx.doi.org/10.1016/j.msard.2022.104009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250418/
https://www.ncbi.nlm.nih.gov/pubmed/35797803
http://dx.doi.org/10.1016/j.msard.2022.104009

Ejemplares similares